Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Reichert

Showing results (331-340 of 336) with videos related to

Pageof 34
Sort By:
You have reached the last page of results.This site can display upto 336 results.
ESMO Gastrointestinal Oncology|February 6, 2026
TROPHIT1-a randomized, open-label, multicenter, phase II/III trial of sacituzumab govitecan compared to standard of care in metastatic colorectal cancer patientsB C Köhler, G M Haag, L Le Cornet, et al.
Journal of Fish Diseases|May 5, 2017
Validation of a KHV antibody enzyme-linked immunosorbent assay (ELISA)S M Bergmann, Q Wang, W Zeng, et al.
Nature Communications|June 10, 2022
Orgo-Seq integrates single-cell and bulk transcriptomic data to identify cell type specific-driver genes associated with autism spectrum disorderElaine T Lim, Yingleong Chan, Pepper Dawes, et al.
Cytokine|December 14, 2001
Adapting pharmacokinetic properties of a humanized anti-interleukin-8 antibody for therapeutic applications using site-specific pegylationS R Leong, L DeForge, L Presta, et al.
Mabs|March 5, 2014
Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CAJuan Carlos Almagro, Gary L Gilliland, Felix Breden, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
c-Rel drives pancreatic cancer metastasis through Fibronectin-Integrin signaling-induced isolation stress resistance and EMT activationD Bakırdöğen, K Görgülü, J Xin, et al.
Pageof 34

Showing results (331-340 of 336) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 336 results.
ESMO Gastrointestinal Oncology|February 6, 2026
TROPHIT1-a randomized, open-label, multicenter, phase II/III trial of sacituzumab govitecan compared to standard of care in metastatic colorectal cancer patientsB C Köhler, G M Haag, L Le Cornet, et al.
Journal of Fish Diseases|May 5, 2017
Validation of a KHV antibody enzyme-linked immunosorbent assay (ELISA)S M Bergmann, Q Wang, W Zeng, et al.
Nature Communications|June 10, 2022
Orgo-Seq integrates single-cell and bulk transcriptomic data to identify cell type specific-driver genes associated with autism spectrum disorderElaine T Lim, Yingleong Chan, Pepper Dawes, et al.
Cytokine|December 14, 2001
Adapting pharmacokinetic properties of a humanized anti-interleukin-8 antibody for therapeutic applications using site-specific pegylationS R Leong, L DeForge, L Presta, et al.
Mabs|March 5, 2014
Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CAJuan Carlos Almagro, Gary L Gilliland, Felix Breden, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
c-Rel drives pancreatic cancer metastasis through Fibronectin-Integrin signaling-induced isolation stress resistance and EMT activationD Bakırdöğen, K Görgülü, J Xin, et al.
Pageof 34